Author: | Park, J. H. |
Article Title: | ATRA plus arsenic gets another "A" in APL |
Abstract: | In this issue of Blood, Iland et al report that the addition of arsenic trioxide during induction and consolidation can substantially reduce the amount of chemotherapy and the duration of consolidation to achieve excellent outcomes in patients with newly diagnosed acute promyelocytic leukemia (APL; see figure). (Figure Presented). |
Keywords: | cancer survival; treatment outcome; treatment response; survival rate; note; disease free survival; methotrexate; follow up; arsenic trioxide; survival time; cancer regression; promyelocytic leukemia; idarubicin; retinoic acid |
Journal Title: | Blood |
Volume: | 120 |
Issue: | 8 |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2012-08-23 |
Start Page: | 1535 |
End Page: | 1536 |
Language: | English |
DOI: | 10.1182/blood-2012-07-439547 |
PROVIDER: | scopus |
PUBMED: | 22918418 |
DOI/URL: | |
Notes: | --- - "Export Date: 1 October 2012" - "CODEN: BLOOA" - "Source: Scopus" |